These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
216 related items for PubMed ID: 17096728
1. Organ-specific endoglin (CD105) expression in the angiogenesis of human cancers. Minhajat R, Mori D, Yamasaki F, Sugita Y, Satoh T, Tokunaga O. Pathol Int; 2006 Dec; 56(12):717-23. PubMed ID: 17096728 [Abstract] [Full Text] [Related]
10. Role of tumor suppressor and angiogenesis markers in prediction of recurrence of non muscle invasive bladder cancer. Agrawal U, Mishra AK, Salgia P, Verma S, Mohanty NK, Saxena S. Pathol Oncol Res; 2011 Mar 01; 17(1):91-101. PubMed ID: 20571940 [Abstract] [Full Text] [Related]
11. Endoglin (CD 105) is expressed on endothelial cells in the primary central nervous system lymphomas and correlates with survival. Sugita Y, Takase Y, Mori D, Tokunaga O, Nakashima A, Shigemori M. J Neurooncol; 2007 May 01; 82(3):249-56. PubMed ID: 17102906 [Abstract] [Full Text] [Related]
12. Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and anti-CD105 antibody. Tanaka F, Otake Y, Yanagihara K, Kawano Y, Miyahara R, Li M, Yamada T, Hanaoka N, Inui K, Wada H. Clin Cancer Res; 2001 Nov 01; 7(11):3410-5. PubMed ID: 11705856 [Abstract] [Full Text] [Related]
13. Transforming growth factor-beta1 and CD105 promote the migration of hepatocellular carcinoma-derived endothelium. Benetti A, Berenzi A, Gambarotti M, Garrafa E, Gelati M, Dessy E, Portolani N, Piardi T, Giulini SM, Caruso A, Invernici G, Parati EA, Nicosia R, Alessandri G. Cancer Res; 2008 Oct 15; 68(20):8626-34. PubMed ID: 18922939 [Abstract] [Full Text] [Related]
15. Laryngeal carcinoma recurrence rate and disease-free interval are related to CD105 expression but not to vascular endothelial growth factor 2 (Flk-1/Kdr) expression. Marioni G, Giacomelli L, D'Alessandro E, Staffieri C, Guzzardo V, Staffieri A, Blandamura S. Anticancer Res; 2008 Oct 15; 28(1B):551-7. PubMed ID: 18383901 [Abstract] [Full Text] [Related]
16. Characterization of CD45-/CD31+/CD105+ circulating cells in the peripheral blood of patients with gynecologic malignancies. Yu HK, Lee HJ, Choi HN, Ahn JH, Choi JY, Song HS, Lee KH, Yoon Y, Yi LS, Kim JS, Kim SJ, Kim TJ. Clin Cancer Res; 2013 Oct 01; 19(19):5340-50. PubMed ID: 23922300 [Abstract] [Full Text] [Related]
17. Comparative evaluation of microvessel density determined by CD34 or CD105 in benign and malignant gastric lesions. Ding S, Li C, Lin S, Yang Y, Liu D, Han Y, Zhang Y, Li L, Zhou L, Kumar S. Hum Pathol; 2006 Jul 01; 37(7):861-6. PubMed ID: 16784986 [Abstract] [Full Text] [Related]